Percheron Therapeutics Limited

DB:AWY0 Stock Report

Market Cap: €5.9m

Percheron Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:AWY0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Jan 25Buy€131,835Powerhouse Ventures LimitedCompany25,000,000€0.0055
06 Jan 25Buy€251,512Powerhouse Ventures LimitedCompany55,000,000€0.0052
31 Dec 24Buy€8,965Charmaine GittlesonIndividual1,666,666€0.0054
31 Dec 24Buy€235,213Gregory PetersIndividual11,705,710€0.021
24 Dec 24Buy€6,295James GarnerIndividual1,500,000€0.0042
18 Dec 24Sell€511,455Platinum Investment Management LimitedCompany90,972,640€0.042
27 Nov 24Buy€5,492James GarnerIndividual125,000€0.044
21 Nov 24Buy€13,673Robert MosesIndividual300,000€0.046
14 Nov 24Buy€21,455Statemoor Pty LtdCompany437,500€0.049
15 Oct 24Sell€461,178Platinum Investment Management LimitedCompany6,399,850€0.083
11 Oct 24Buy€109,451Dale ReedIndividual1,978,157.86€0.055
24 Apr 24Sell€520,802Platinum Investment Management LimitedCompany14,488,464€0.036

Insider Trading Volume

Insider Buying: AWY0 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AWY0?
Owner TypeNumber of SharesOwnership Percentage
Institutions10,000,0000.92%
VC/PE Firms80,000,0007.36%
Private Companies82,075,8737.55%
Individual Insiders111,811,64210.3%
General Public803,550,11873.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.6%.

Top Shareholders

Top 25 shareholders own 25.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.36%
Powerhouse Ventures Limited
80,000,000€433.7k0%34.82%
3.35%
Mutual Investments Pty Ltd
36,448,120€197.6k70.6%no data
1.53%
Gregory Peters
16,605,710€90.0k0%no data
1.38%
Dale Reed
15,050,000€81.6k15.3%no data
1.38%
Jamplat Pty Limited
15,000,000€81.3k5.26%no data
1.13%
Esarad Holdings Pty Ltd
12,300,888€66.7k0%no data
1.07%
Leon Serry
11,688,075€63.4k0%no data
0.92%
Platinum Investment Management Limited
10,000,000€54.2k-89.6%no data
0.89%
Phillip Hains
9,711,631€52.7k0%no data
0.78%
Robert Moses
8,500,000€46.1k-8.6%no data
0.64%
Shared Office Services Pty Ltd
6,946,304€37.7k0%no data
0.58%
Glen Hanly
6,265,005€34.0k4.16%no data
0.55%
Statemoor Pty Ltd
5,937,500€32.2k22.9%no data
0.46%
Carl Charalambous
5,000,000€27.1k0%no data
0.45%
Mark Diamond
4,893,722€26.5k0%no data
0.39%
Robertson Mitchell
4,227,660€22.9k7.64%no data
0.39%
Karen Mitchell
4,227,659€22.9k7.64%no data
0.38%
David Kenley
4,138,810€22.4k0%no data
0.31%
Jesse Hedley
3,345,000€18.1k8.34%no data
0.31%
Katie Hedley
3,345,000€18.1k8.34%no data
0.29%
XEC Partners Pty Ltd
3,204,358€17.4k0%no data
0.28%
James Garner
3,000,000€16.3k200%no data
0.26%
George Tachas
2,863,566€15.5k0%no data
0.26%
Margaret Ryan
2,775,000€15.0k16.4%no data
0.26%
Michael Ryan
2,775,000€15.0k16.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 15:33
End of Day Share Price 2025/01/17 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Percheron Therapeutics Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Iain WilkieMorgans Financial Limited
Dr StoreyWilsons Advisory and Stockbroking Ltd.